You see a filtered list - Keywords: Lederle-Selection
[1]S. Zafarnia, J. Bzyl-Ibach, I. Spivak, Y. Li, S. Koletnik, D. Doleschel, A. Rix, S. Pochon, I. Tardy, S. Koyadan, M. van Zandvoort, M. Palmowski, F. Kießling, W. Lederle,
"Nilotinib Enhances Tumor Angiogenesis and Counteracts VEGFR2 Blockade in an Orthotopic Breast Cancer Xenograft Model with Desmoplastic Response", Neoplasia, vol. 19, no. 11, 2017, pp. 896–907.
[bibtex] [url] [doi]
[2]T. Repenko, A. Rix, S. Ludwanowski, D. Go, F. Kießling, W. Lederle, A. J. C. Kühne,
"Bio-degradable highly fluorescent conjugated polymer nanoparticles for bio-medical imaging applications", Nature Communications, vol. 8, no. 1, 2017, pp. 470.
[bibtex] [url] [doi]
[3]S. C. Baetke, A. Rix, F. Tranquart, R. Schneider, T. Lammers, F. Kießling, W. Lederle,
"Squamous Cell Carcinoma Xenografts: Use of VEGFR2-targeted Microbubbles for Combined Functional and Molecular US to Monitor Antiangiogenic Therapy Effects", Radiology, vol. 278, no. 2, 2016, pp. 430–440.
[bibtex] [url] [doi]
[4]J. G. Torres-Rendon, T. Femmer, L. De Laporte, T. Tigges, K. Rahimi, F. Gremse, S. Zafarnia, W. Lederle, S. Ifuku, M. Wessling, J. G. Hardy, A. Walther,
"Bioactive Gyroid Scaffolds Formed by Sacrificial Templating of Nanocellulose and Nanochitin Hydrogels as Instructive Platforms for Biomimetic Tissue Engineering", Advanced materials, vol. 27, no. 19, 2015, pp. 2989–2995.
[bibtex] [url] [doi]
[5]D. Doleschel, A. Rix, S. Arns, K. Palmowski, F. Gremse, R. Merkle, F. Salopiata, U. Klingmüller, M. Jarsch, F. Kießling, W. Lederle,
"Erythropoietin Improves the Accumulation and Therapeutic Effects of Carboplatin by Enhancing Tumor Vascularization and Perfusion", Theranostics, vol. 5, no. 8, 2015, pp. 905–918.
[bibtex] [url] [doi]
[6]W. Al Rawashdeh, S. Arns, F. Gremse, J. L. A. Ehling, R. Knüchel-Clarke, S. Kray, F. Spöler, F. Kießling, W. Lederle,
"Optical Tomography of MMP Activity Allows a Sensitive Noninvasive Characterization of the Invasiveness and Angiogenesis of SCC Xenografts", Neoplasia, vol. 16, no. 3, 2014, pp. 235–246.
[bibtex] [url] [doi]
[7]J. Bzyl, M. Palmowski, A. Rix, S. Arns, J. Hyvelin, S. Pochon, J. L. A. Ehling, S. Schrading, F. Kießling, W. Lederle,
"The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55)", European radiology, vol. 23, no. 2, 2013, pp. 468–475.
[bibtex] [url] [doi]
[8]L. Abou-Elkacem, S. Arns, G. Brix, F. Gremse, D. Zopf, F. Kießling, W. Lederle,
"Regorafenib Inhibits Growth, Angiogenesis, and Metastasis in a Highly Aggressive, Orthotopic Colon Cancer Model", Molecular cancer therapeutics, vol. 12, no. 7, 2013, pp. 1322–1331.
[bibtex] [url] [doi]
[9]D. Doleschel, O. Mundigl, A. Wessner, F. Gremse, J. Bachmann, A. Rodriguez, U. Klingmüller, M. Jarsch, F. Kießling, W. Lederle,
"Targeted Near-Infrared Imaging of the Erythropoietin Receptor in Human Lung Cancer Xenografts", Journal of nuclear medicine, vol. 53, no. 2, 2012, pp. 304–311.
[bibtex] [url] [doi]
[10]S. Depner, W. Lederle, C. M. Gutschalk, N. Linde, A. Zajonz, M. M. Mueller,
"Cell type specific interleukin-6 induced responses in tumor keratinocytes and stromal fibroblasts are essential for invasive growth", International journal of cancer, vol. 135, no. 3, 2012, pp. 551–562.
[bibtex] [url] [doi]